4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-22-006726
Chief Executive Officer acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GOTTSCHALK ADRIAN Chief Executive Officer | 2022-09-16 | Option exercise | +40,000 | $0.54 | $21,600 | 186,479 | D |
| Derivatives | |||||||
| GOTTSCHALK ADRIAN Chief Executive Officer | 2022-09-16 | Option exercise · Stock Option (right to buy) | −40,000 | 418,925 | D | ||
Loading xslF345X03/primarydocument.xml…